MINIMAL RESIDUAL DISEASE
Clinical trials for MINIMAL RESIDUAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new MINIMAL RESIDUAL DISEASE trials appear
Sign up with your email to follow new studies for MINIMAL RESIDUAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to hunt down hidden cancer after treatment
Disease control Recruiting nowThis study is testing whether a combination of two drugs, fruquintinib and tislelizumab, can help control colorectal cancer in patients who have finished their initial chemotherapy but still have tiny amounts of cancer left in their body, detected by a special blood test. The goa…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Scientists test 'Supercharged' immune cells to hunt down lingering cancer
Disease control Recruiting nowThis early-stage study is testing a new combination treatment for people with colorectal cancer who have had surgery but still have tiny amounts of cancer left in their blood. Researchers are giving patients specially engineered immune cells from donated cord blood, along with an…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Engineered immune cells target Leukemia's return
Disease control Recruiting nowThis early-stage trial is testing a new cell therapy for children and adults whose leukemia has come back or persists after a donor stem cell transplant. Doctors take immune cells (T cells) from the original donor, genetically modify them to better recognize and attack the patien…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC
-
Scientists test new blood test to catch lung Cancer's return
Knowledge-focused Recruiting nowThis study aims to develop a new, non-invasive way to monitor lung cancer patients after surgery to see if the cancer might come back. Researchers will collect blood samples from 100 patients who have had lung cancer surgery and analyze them using advanced computer programs. The …
Matched conditions: MINIMAL RESIDUAL DISEASE
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Massive cancer sample bank seeks 100,000 volunteers to unlock medical mysteries
Knowledge-focused Recruiting nowThis study is building a large collection of tissue samples and health information from people to help researchers develop better ways to detect and treat cancer. It aims to enroll 100,000 adults who can provide consent. The goal is to create a shared resource for scientists to s…
Matched conditions: MINIMAL RESIDUAL DISEASE
Sponsor: Caris Science, Inc. • Aim: Knowledge-focused
Last updated Mar 03, 2026 14:07 UTC